Cytokines et sepsis graves. [Cytokines and severe sepsis]

Détails

ID Serval
serval:BIB_2F9F1D83C0DD
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Cytokines et sepsis graves. [Cytokines and severe sepsis]
Périodique
Revue du Praticien
Auteur(s)
Baumgartner  J. D., Heumann  D.
ISSN
0035-2640
Statut éditorial
Publié
Date de publication
03/1993
Volume
43
Numéro
5
Pages
559-63
Notes
English Abstract
Journal Article
Review --- Old month value: Mar 1
Résumé
During severe sepsis syndromes, almost every gene coding for cytokines may be activated. The primary purpose of this activation is to defend the organism against infection, but sometimes these inflammatory mediators go out of control. The reasons why this may occur is unclear because the regulation of cytokines production is still poorly understood. Metabolic effects, production of endothelial adhesion molecules and triggering of neutrophils are some important consequences of cytokine overstimulation which may lead to the clinical picture of septic shock. The major cytokines involved in septic shock are tumor necrosis factor alpha (TNF) and interleukin-1 (IL-1). Both may induce lethal shock in experimental models. The effects of these 2 cytokines are difficult to differentiate from one another because they share many similar biological effects, one can induce the synthesis of the other, and they are strikingly synergistic with each other. gamma-interferon may amplify the inflammatory response by stimulating the cells of monocytic lineage and by increasing TNF-receptor expression, thus participating in the pathogenesis of the septic syndrome. The role of other cytokines is still poorly known. Clinical studies with anti-TNF monoclonal antibodies or with an IL-1 receptor antagonist are under way.
Mots-clé
Animals Bacterial Infections/*physiopathology Cytokines/*physiology Humans Interferon Type II/physiology Interleukin-1/physiology Tumor Necrosis Factor-alpha/physiology
Pubmed
Création de la notice
19/01/2008 18:12
Dernière modification de la notice
20/08/2019 13:14
Données d'usage